Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Saloume Mehrlatifan, Seyyedeh Masumeh Mirnurollahi, Fatemeh Motevalli, Pooneh Rahimi, Sepehr Soleymani & Azam Bolhassani. (2016) The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model. Drug Delivery 23:8, pages 2852-2859.
Read now
Read now
Articles from other publishers (47)
Adane Adugna. (2023) Therapeutic strategies and promising vaccine for hepatitis C virus infection. Immunity, Inflammation and Disease 11:8.
Crossref
Crossref
Eleanor Barnes, Graham S. Cooke, Georg M. Lauer & Raymond T. Chung. (2023) Implementation of a controlled human infection model for evaluation of HCV vaccine candidates. Hepatology 77:5, pages 1757-1772.
Crossref
Crossref
Nicole E. Skinner, Nicole Frumento & Justin R. Bailey. 2023. Plotkin's Vaccines. Plotkin's Vaccines
433
442.e5
.
Chunyan Yi, Jing Xia, Lan He, Zhiyang Ling, Xuesong Wang, Yu Yan, Jiangjun Wang, Xinhao Zhao, Weiguo Fan, Xiaoyu Sun, Ronghua Zhang, Sheng Ye, Rongguang Zhang, Yongfen Xu, Liyan Ma, Yaguang Zhang, Honglin Zhou, Zhong Huang, Junqi Niu, Gang Long, Junxia Lu, Jin Zhong & Bing Sun. (2020) Junctional and somatic hypermutation-induced CX4C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody. Cellular & Molecular Immunology 18:3, pages 675-685.
Crossref
Crossref
Luisa J. Ströh & Thomas Krey. (2020) HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development. International Journal of Molecular Sciences 21:18, pages 6781.
Crossref
Crossref
María Q. Marín, Kwinten Sliepen, Juan García-Arriaza, Sylvie M. Koekkoek, Patricia Pérez, Carlos Óscar S. Sorzano, Carmen E. Gómez, Rogier W. Sanders & Mariano Esteban. (2020) Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV. Vaccines 8:3, pages 440.
Crossref
Crossref
Rob J. Center, Irene Boo, Lilian Phu, Joey McGregor, Pantelis Poumbourios & Heidi E. Drummer. (2020) Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine. Journal of Biological Chemistry 295:21, pages 7179-7192.
Crossref
Crossref
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban & Juan García-Arriaza. (2019) Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Journal of Virology 93:7.
Crossref
Crossref
Maryann C. Ezeilo, Godwill A. Engwa, Romanus I. Iroha & Damian N. Odimegwu. (2018) High Anti-HCV Seroprevalence and Low Performance of ICT Strip in Diagnosing Hepatitis C Virus Infection in Children in Enugu Metropolis. The Open Virology Journal 12:1, pages 149-156.
Crossref
Crossref
Gregory R Hart & Andrew L Ferguson. (2018) Computational design of hepatitis C virus immunogens from host-pathogen dynamics over empirical viral fitness landscapes. Physical Biology 16:1, pages 016004.
Crossref
Crossref
Luisa J. Ströh, Kumar Nagarathinam & Thomas Krey. (2018) Conformational Flexibility in the CD81-Binding Site of the Hepatitis C Virus Glycoprotein E2. Frontiers in Immunology 9.
Crossref
Crossref
Xuan Guo, Jin-Yi Zhong & Jun-Wen Li. (2018) Hepatitis C Virus Infection and Vaccine Development. Journal of Clinical and Experimental Hepatology 8:2, pages 195-204.
Crossref
Crossref
Danushka K. Wijesundara, Jason Gummow, Yanrui Li, Wenbo Yu, Benjamin J. Quah, Charani Ranasinghe, Joseph Torresi, Eric J. Gowans & Branka Grubor-Bauk. (2018) Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice. Journal of Virology 92:8.
Crossref
Crossref
Sergio Abrignani, Petra Neddermann, Michael Houghton & Raffaele De Francesco. 2018. Plotkin's Vaccines. Plotkin's Vaccines
375
385.e5
.
Shaogeng Zhang, Fang Sun, Tianyu Ren, Yueqiang Duan, Hongjing Gu, Chengcai Lai, Zhaohai Wang, Peirui Zhang, Xiliang Wang & Penghui Yang. (2017) Immunogenicity of an influenza virus-vectored vaccine carrying the hepatitis C virus protein epitopes in mice. Antiviral Research 145, pages 168-174.
Crossref
Crossref
Patricia T. Vietheer, Irene Boo, Jun Gu, Kathleen McCaffrey, Stirling Edwards, Catherine Owczarek, Matthew P. Hardy, Louis Fabri, Rob J. Center, Pantelis Poumbourios & Heidi E. Drummer. (2017) The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs. Hepatology 65:4, pages 1117-1131.
Crossref
Crossref
Qiu-Feng He, Qiong-Fang Zhang & Da-Zhi Zhang. (2016) Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis. Digestive Diseases and Sciences 61:11, pages 3108-3117.
Crossref
Crossref
C S Rollier, E J Verschoor, B E Verstrepen, J A R Drexhage, G Paranhos-Baccala, P Liljeström, G Sutter, L Arribillaga, J J Lasarte, B Bartosch, F-L Cosset, G Inchauspe & J L Heeney. (2016) T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates. Gene Therapy 23:10, pages 753-759.
Crossref
Crossref
Leo Swadling, John Halliday, Christabel Kelly, Anthony Brown, Stefania Capone, M. Ansari, David Bonsall, Rachel Richardson, Felicity Hartnell, Jane Collier, Virginia Ammendola, Mariarosaria Del Sorbo, Annette Von Delft, Cinzia Traboni, Adrian Hill, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Paul Klenerman, Antonella Folgori & Eleanor Barnes. (2016) Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines 4:3, pages 27.
Crossref
Crossref
Christine S. Rollier, Adrian V.S. Hill & Arturo Reyes-Sandoval. (2016) Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses. Vaccine 34:38, pages 4470-4474.
Crossref
Crossref
Kouka Saadeldin Abdelwahab. (2016) Status of hepatitis C virus vaccination: Recent update. World Journal of Gastroenterology 22:2, pages 862.
Crossref
Crossref
Paul Klenerman & Karen Fitzmaurice. (2015) An update on hepatitis C virus. Clinical Medicine 15:Suppl 6, pages s33-s36.
Crossref
Crossref
Gregory R Hart & Andrew L Ferguson. (2015) Empirical fitness models for hepatitis C virus immunogen design. Physical Biology 12:6, pages 066006.
Crossref
Crossref
Mark W. Robinson, Elihu Aranday‐Cortes, Derek Gatherer, Rachael Swann, Jolanda M. P. Liefhebber, Ana Da Silva Filipe, Alex Sigruener, Stephen T. Barclay, Peter R. Mills, Arvind H. Patel & John McLauchlan. (2015) Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection. Liver International 35:10, pages 2256-2264.
Crossref
Crossref
Wei Yang, Meng Zhang, Xiaojing Chi, Xiuying Liu, Bo Qin & Sheng Cui. (2015) An intramolecular bond at cluster of differentiation 81 ectodomain is important for hepatitis C virus entry. The FASEB Journal 29:10, pages 4214-4226.
Crossref
Crossref
Jason Gummow, Yanrui Li, Wenbo Yu, Tamsin Garrod, Danushka Wijesundara, Amelia J. Brennan, Ranajoy Mullick, Ilia Voskoboinik, Branka Grubor-Bauk & Eric J. Gowans. (2015) A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice. Journal of Virology 89:15, pages 7991-8002.
Crossref
Crossref
S.J. Hullegie, J.E. Arends, B.J.A. Rijnders, W.L. Irving, D. Salmon, M. Prins, A.M. Wensing, P. Klenerman, H. Leblebicioglu, C. Boesecke, J.K. Rockstroh & A.I.M. Hoepelman. (2015) Current knowledge and future perspectives on acute hepatitis C infection. Clinical Microbiology and Infection 21:8, pages 797.e9-797.e17.
Crossref
Crossref
E. F. Kolesanova, B. N. Sobolev, A. A. Moysa, E. A. Egorova & A. I. Archakov. (2015) The way to the peptide vaccine against hepatitis C. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 9:3, pages 217-227.
Crossref
Crossref
Li He, Aiping Zang, Min Du, Dapeng Ma, Chuanping Yuan, Chun Zhou, Jing Mu, Huanjing Shi, Dapeng Li, Xulin Huang, Qiang Deng, Jianhua Xiao, Huimin Yan, Lijian Hui, Ke Lan, Sidong Xiong, Xiaoxia Li, Zhong Huang & Hui Xiao. (2015) mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines. Virologica Sinica 30:3, pages 174-189.
Crossref
Crossref
Rama S. AkondyPhilip L. F. Johnson, Helder I. Nakaya, Srilatha EdupugantiMark J. MulliganBenton Lawson, Joseph D. MillerBali Pulendran, Rustom Antia & Rafi Ahmed. (2015) Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination. Proceedings of the National Academy of Sciences 112:10, pages 3050-3055.
Crossref
Crossref
E.F. Kolesanova, B.N. Sobolev, A.A. Moysa, E.A. Egorova & A.I. Archakov. (2015) Way to the peptide vaccine against hepatitis C. Biomeditsinskaya Khimiya 61:2, pages 254-264.
Crossref
Crossref
April M. Young, Dustin B. Stephens, Hanan A. Khaleel & Jennifer R. Havens. (2015) Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment. Contemporary Clinical Trials 41, pages 9-16.
Crossref
Crossref
Carolyn Rydyznski, Keith A. Daniels, Erik P. Karmele, Taylor R. Brooks, Sarah E. Mahl, Michael T. Moran, Caimei Li, Rujapak Sutiwisesak, Raymond M. Welsh & Stephen N. Waggoner. (2015) Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells. Nature Communications 6:1.
Crossref
Crossref
Jane P. Messina, Isla Humphreys, Abraham Flaxman, Anthony Brown, Graham S. Cooke, Oliver G. Pybus & Eleanor Barnes. (2014) Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61:1, pages 77-87.
Crossref
Crossref
Leo SwadlingStefania CaponeRichard D. AntrobusAnthony BrownRachel RichardsonEvan W. NewellJohn HallidayChristabel KellyDan BowenJoannah FergussonAyako KuriokaVirginia AmmendolaMariarosaria Del SorboFabiana GrazioliMaria Luisa EspositoLoredana SianiCinzia TraboniAdrian HillStefano CollocaMark DavisAlfredo NicosiaRiccardo CorteseAntonella FolgoriPaul KlenermanEleanor Barnes. (2014) A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory. Science Translational Medicine 6:261.
Crossref
Crossref
Mina John & Silvana Gaudieri. (2014) Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines. Frontiers in Microbiology 5.
Crossref
Crossref
Alicja M. Chmielewska, Mariarosaria Naddeo, Stefania Capone, Virginia Ammendola, Ke Hu, Luke Meredith, Lieven Verhoye, Malgorzata Rychlowska, Rino Rappuoli, Jeffrey B. Ulmer, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese, Geert Leroux-Roels, Peter Balfe, Krystyna Bienkowska-Szewczyk, Philip Meuleman, Jane A. McKeating & Antonella Folgori. (2014) Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses. Journal of Virology 88:10, pages 5502-5510.
Crossref
Crossref
Wen-Hsuan W. Lin, Chien-Hsiung Pan, Robert J. Adams, Beth L. Laube & Diane E. Griffin. (2014) Vaccine-Induced Measles Virus-Specific T Cells Do Not Prevent Infection or Disease but Facilitate Subsequent Clearance of Viral RNA. mBio 5:2.
Crossref
Crossref
C. Zingaretti, R. De Francesco & S. Abrignani. (2014) Why is it so difficult to develop a hepatitis C virus preventive vaccine?. Clinical Microbiology and Infection 20, pages 103-109.
Crossref
Crossref
Stefania Capone, Mariarosaria Naddeo, Anna Morena D'Alise, Adele Abbate, Fabiana Grazioli, Annunziata Del Gaudio, Mariarosaria Del Sorbo, Maria Luisa Esposito, Virginia Ammendola, Gemma Perretta, Alessandra Taglioni, Stefano Colloca, Alfredo Nicosia, Riccardo Cortese & Antonella Folgori. (2014) Fusion of HCV Nonstructural Antigen to MHC Class II–associated Invariant Chain Enhances T-cell Responses Induced by Vectored Vaccines in Nonhuman Primates. Molecular Therapy 22:5, pages 1039-1047.
Crossref
Crossref
Supanee Potisopon, Stéphane Priet, Barbara SeliskoBruno Canard. (2014) Comparison of dengue virus and HCV: from impact on global health to their RNA-dependent RNA polymerases. Future Virology 9:1, pages 53-67.
Crossref
Crossref
Mark Thursz & Arnaud Fontanet. (2013) HCV transmission in industrialized countries and resource-constrained areas. Nature Reviews Gastroenterology & Hepatology 11:1, pages 28-35.
Crossref
Crossref
Ponni V. Perumalswami & Robert S. Klein. 2014. Viral Infections of Humans. Viral Infections of Humans
765
783
.
Maryam Yazdanian, Arash Memarnejadian, Mehdi Mahdavi, Seyed Mehdi Sadat, Fatemeh Motevali, Rouhollah Vahabpour, Hossein Khanahmad, Seyed Davar Siadat, Mohammad Reza Aghasadeghi & Farzin Roohvand. (2013) Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer. Hepatitis Monthly 13:10.
Crossref
Crossref
Judith M. Gottwein & Jens Bukh. (2013) Cell-culture-derived HCV—a promising vaccine antigen. Nature Reviews Gastroenterology & Hepatology 10:9, pages 508-509.
Crossref
Crossref
Michael Houghton, John Lokman Law & D. Lorne Tyrrell. (2013) An Inactivated Hepatitis C Virus Vaccine on the Horizon?. Gastroenterology 145:2, pages 285-288.
Crossref
Crossref
Magdalena Molero-Abraham, Esther M. Lafuente, Darren R. Flower & Pedro A. Reche. (2013) Selection of Conserved Epitopes from Hepatitis C Virus for Pan-Populational Stimulation of T-Cell Responses. Clinical and Developmental Immunology 2013, pages 1-10.
Crossref
Crossref